Use Latest Tech To Develop Green Pharma City: CM Revanth Reddy To Officials

HYDERABAD: Directing officials to expedite the development of Green Pharma City at Mucharla, Chief Minister A Revanth Reddy said that the latest global technology available should be used for its development.

On Monday, the chief minister held a review meeting with officials. He directed them to take all measures necessary to ensure that Green Pharma City remains environmentally sustainable and free from pollution. He stressed that industrial development should not cause any inconvenience to the people in surrounding areas.

Revanth told them to construct roads and take steps to provide drinking water, electricity, drainage and other essential infrastructure. He also instructed officials to assess future needs and plan infrastructure accordingly. He mentioned that several prominent pharmaceutical companies are already expressing interest in investing in Green Pharma City, and the government will soon begin consultations with them.

The chief minister said the Green Pharma City should become a one-stop hub for drug manufacturing companies, as well as biotech and life sciences firms. He highlighted that priority will be given to the production of antibiotics, fermentation products, synthetic drugs, chemicals, vitamins, vaccines, drug formulations, nutraceuticals, herbal medicinal products, specialty chemicals, cosmetics, and related products. Additionally, research and development will be a major focus.

He announced that a special university will be established within the city for research, training and skill development, with courses designed to enhance employment opportunities in the healthcare and pharma sectors.

IT and Industries Minister D Sridhar Babu, Chief Secretary Santhi Kumari, Principal Secretary (Industries) Department Jayesh Ranjan and other officials attended the meeting.

Related Posts

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

Stents to syringes: Serious harm reports surge, but makers remain unnamed

6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick